2nd International Symposium on Reverse Cholesterol Transport: Report on a meeting

A. G. Lacko, P. H. Pritchard

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The purpose of this symposium was to provide a forum for presenting recent findings and for exchange of ideas concerning reverse cholesterol transport. Because the mechanism involving HDL in the prevention and/or reversal of atherosclerosis is still unknown, this area is of intense interest. Although reverse cholesterol transport as an essential physiological mechanism has been validated, the clinical significance of this pathway remains unclear. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, this second conference involving the leading investigators proved particularly valuable for presentation and extensive discussion of unpublished and occasionally controversial findings. Following this conference, an agreement was reached between the organizers and Dr. Norman E. Miller to combine this symposium with the previously held International Symposia on High Density Lipoproteins in Atherosclerosis (organized by Dr. Miller).

Original languageEnglish
Pages (from-to)351-356
Number of pages6
JournalJournal of Lipid Research
Volume35
Issue number2
StatePublished - 1 Jan 1994

Fingerprint

Cholesterol
Atherosclerosis
Critical Pathways
HDL Lipoproteins
Metabolism
Research Personnel
Tissue

Cite this

@article{b797e7ede0564fd78316a3c5b6c3c26e,
title = "2nd International Symposium on Reverse Cholesterol Transport: Report on a meeting",
abstract = "The purpose of this symposium was to provide a forum for presenting recent findings and for exchange of ideas concerning reverse cholesterol transport. Because the mechanism involving HDL in the prevention and/or reversal of atherosclerosis is still unknown, this area is of intense interest. Although reverse cholesterol transport as an essential physiological mechanism has been validated, the clinical significance of this pathway remains unclear. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, this second conference involving the leading investigators proved particularly valuable for presentation and extensive discussion of unpublished and occasionally controversial findings. Following this conference, an agreement was reached between the organizers and Dr. Norman E. Miller to combine this symposium with the previously held International Symposia on High Density Lipoproteins in Atherosclerosis (organized by Dr. Miller).",
author = "Lacko, {A. G.} and Pritchard, {P. H.}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "351--356",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

2nd International Symposium on Reverse Cholesterol Transport : Report on a meeting. / Lacko, A. G.; Pritchard, P. H.

In: Journal of Lipid Research, Vol. 35, No. 2, 01.01.1994, p. 351-356.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 2nd International Symposium on Reverse Cholesterol Transport

T2 - Report on a meeting

AU - Lacko, A. G.

AU - Pritchard, P. H.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The purpose of this symposium was to provide a forum for presenting recent findings and for exchange of ideas concerning reverse cholesterol transport. Because the mechanism involving HDL in the prevention and/or reversal of atherosclerosis is still unknown, this area is of intense interest. Although reverse cholesterol transport as an essential physiological mechanism has been validated, the clinical significance of this pathway remains unclear. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, this second conference involving the leading investigators proved particularly valuable for presentation and extensive discussion of unpublished and occasionally controversial findings. Following this conference, an agreement was reached between the organizers and Dr. Norman E. Miller to combine this symposium with the previously held International Symposia on High Density Lipoproteins in Atherosclerosis (organized by Dr. Miller).

AB - The purpose of this symposium was to provide a forum for presenting recent findings and for exchange of ideas concerning reverse cholesterol transport. Because the mechanism involving HDL in the prevention and/or reversal of atherosclerosis is still unknown, this area is of intense interest. Although reverse cholesterol transport as an essential physiological mechanism has been validated, the clinical significance of this pathway remains unclear. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, this second conference involving the leading investigators proved particularly valuable for presentation and extensive discussion of unpublished and occasionally controversial findings. Following this conference, an agreement was reached between the organizers and Dr. Norman E. Miller to combine this symposium with the previously held International Symposia on High Density Lipoproteins in Atherosclerosis (organized by Dr. Miller).

UR - http://www.scopus.com/inward/record.url?scp=0028084340&partnerID=8YFLogxK

M3 - Article

C2 - 8169538

AN - SCOPUS:0028084340

VL - 35

SP - 351

EP - 356

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 2

ER -